Clinical Trial Update: Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating raltitrexed-based chemotherapy plus bevacizumab in patients with advanced colorectal cancer who have been retreated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Raltitrexed (Raltitrexed)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: UNKNOWN